BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33604389)

  • 1. Recombinant
    Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
    J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells.
    Souza BM; Preisser TM; Pereira VB; Zurita-Turk M; de Castro CP; da Cunha VP; de Oliveira RP; Gomes-Santos AC; de Faria AM; Machado DC; Chatel JM; Azevedo VA; Langella P; Miyoshi A
    Microb Cell Fact; 2016 Aug; 15(1):150. PubMed ID: 27576902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.
    Zurita-Turk M; Del Carmen S; Santos AC; Pereira VB; Cara DC; Leclercq SY; de LeBlanc Ad; Azevedo V; Chatel JM; LeBlanc JG; Miyoshi A
    BMC Biotechnol; 2014 Aug; 14():73. PubMed ID: 25106058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice.
    Liu KF; Liu XR; Li GL; Lu SP; Jin L; Wu J
    Immunol Lett; 2016 Jun; 174():28-36. PubMed ID: 27085380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice.
    Ma Y; Liu J; Hou J; Dong Y; Lu Y; Jin L; Cao R; Li T; Wu J
    PLoS One; 2014; 9(8):e105701. PubMed ID: 25157497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.
    Ko KS; Lee M; Koh JJ; Kim SW
    Mol Ther; 2001 Oct; 4(4):313-6. PubMed ID: 11592833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual genetic absence of STAT6 and IL-10 does not abrogate anti-hyperglycemic effects of Schistosoma mansoni in streptozotocin-treated diabetic mice.
    Osada Y; Fujiyama T; Kamimura N; Kaji T; Nakae S; Sudo K; Ishiwata K; Kanazawa T
    Exp Parasitol; 2017 Jun; 177():1-12. PubMed ID: 28363777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice.
    Lang J; Wang X; Liu K; He D; Niu P; Cao R; Jin L; Wu J
    Appl Microbiol Biotechnol; 2017 Oct; 101(20):7653-7662. PubMed ID: 28889199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
    Müller A; Schott-Ohly P; Dohle C; Gleichmann H
    Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of intestinal inflammation in IL-10 deficient mice by a plasmid carrying Lactococcus lactis strain.
    Zurita-Turk M; Mendes Souza B; Prósperi de Castro C; Bastos Pereira V; Pecini da Cunha V; Melo Preisser T; Caetano de Faria AM; Carmona Cara Machado D; Miyoshi A
    BMC Biotechnol; 2020 Jul; 20(1):38. PubMed ID: 32703192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice.
    Pavlovic S; Petrovic I; Jovicic N; Ljujic B; Miletic Kovacevic M; Arsenijevic N; Lukic ML
    Front Immunol; 2018; 9():2646. PubMed ID: 30498495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Delivery of Proinsulin and IL-10 via
    Cook DP; Cunha JPMCM; Martens PJ; Sassi G; Mancarella F; Ventriglia G; Sebastiani G; Vanherwegen AS; Atkinson MA; Van Huynegem K; Steidler L; Caluwaerts S; Rottiers P; Teyton L; Dotta F; Gysemans C; Mathieu C
    Front Immunol; 2020; 11():1103. PubMed ID: 32582188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
    Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
    Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice.
    Seifarth C; Pop S; Liu B; Wong CP; Tisch R
    J Immunol; 2003 Jul; 171(1):469-76. PubMed ID: 12817032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of combined intervention with adenovirus vector mediated IL-10 and IGF-1 genes on endogenous islet β cells in nonobese diabetes mice with onset of type 1 diabetes mellitus.
    Zhang L; Chen Y; Li C; Lin X; Cheng X; Li T
    PLoS One; 2014; 9(3):e92616. PubMed ID: 24663217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes.
    Anastasi E; Campese AF; Bellavia D; Bulotta A; Balestri A; Pascucci M; Checquolo S; Gradini R; Lendahl U; Frati L; Gulino A; Di Mario U; Screpanti I
    J Immunol; 2003 Nov; 171(9):4504-11. PubMed ID: 14568923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
    Goudy KS; Burkhardt BR; Wasserfall C; Song S; Campbell-Thompson ML; Brusko T; Powers MA; Clare-Salzler MJ; Sobel ES; Ellis TM; Flotte TR; Atkinson MA
    J Immunol; 2003 Sep; 171(5):2270-8. PubMed ID: 12928371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice.
    Moritani M; Yoshimoto K; Tashiro F; Hashimoto C; Miyazaki J; Ii S; Kudo E; Iwahana H; Hayashi Y; Sano T
    Int Immunol; 1994 Dec; 6(12):1927-36. PubMed ID: 7696210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.